Form 4: Biodesix Inc. Executive Chris Vazquez Reports Stock Transactions

Chris Vazquez, Chief Accounting Officer of Biodesix Inc., reports the acquisition and disposal of common stock and restricted stock units to cover taxes upon vesting.

Summary

• Chris Vazquez, the Chief Accounting Officer of Biodesix Inc., filed a Form 4 detailing changes in beneficial ownership.
• On August 8, 2024, Vazquez acquired 602 shares of common stock through the vesting of restricted stock units (RSUs).
• On August 9, 2024, 155 shares were sold at a price of $1.601 per share to cover taxes upon the vesting of RSUs.
• On August 12, 2024, 54 shares were sold at a weighted average price of $1.5719 per share, also to cover taxes upon RSU vesting.
• Following these transactions, Vazquez directly owns 11,188 shares of Biodesix Inc. common stock and 3,610 restricted stock units.

Sentiment

Score: 5

Explanation: This is a neutral report on stock transactions by an executive, with no inherent positive or negative implications for the company's overall performance.

Industry Context

This filing is a routine disclosure of stock transactions by a company executive, which is common practice and required by the SEC to ensure transparency and prevent insider trading.

Stakeholder Impact

• The transactions have a minimal impact on shareholders, as they are related to executive compensation and tax obligations.

Key Dates